Xenon Pharmaceuticals Inc.
US ˙ NasdaqGM ˙ CA98420N1050

Introduction

This page provides a comprehensive analysis of the known insider trading history of Pimstone Simon N.. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Pimstone Simon N. has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:XENE / Xenon Pharmaceuticals Inc. Director 6,000
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Pimstone Simon N.. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases XENE / Xenon Pharmaceuticals Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in XENE / Xenon Pharmaceuticals Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2017-08-10 XENE PIMSTONE SIMON N. 6,000 2.9000 6,000 2.9000 17,400 364 12.1 55,200 317.24

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

XENE / Xenon Pharmaceuticals Inc. Insider Trades
Insider Sales XENE / Xenon Pharmaceuticals Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in XENE / Xenon Pharmaceuticals Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2023-06-01 XENE PIMSTONE SIMON N. 7,458 38.9700 7,458 38.9700 290,638 168 28.7000 -76,593 -26.35
2023-06-01 XENE PIMSTONE SIMON N. 24,255 38.7800 24,255 38.7800 940,609
2023-05-31 XENE PIMSTONE SIMON N. 12,000 38.5300 12,000 38.5300 462,360
2023-05-31 XENE PIMSTONE SIMON N. 23,670 38.8100 23,670 38.8100 918,633
2023-05-31 XENE PIMSTONE SIMON N. 26,856 38.6900 26,856 38.6900 1,039,059
2023-05-30 XENE PIMSTONE SIMON N. 18,006 38.6300 18,006 38.6300 695,572
2023-05-30 XENE PIMSTONE SIMON N. 19,000 39.9000 19,000 39.9000 758,100
2023-03-07 XENE PIMSTONE SIMON N. 10,990 37.0100 10,990 37.0100 406,740
2023-03-07 XENE PIMSTONE SIMON N. 8,242 36.9400 8,242 36.9400 304,459
2022-08-16 XENE PIMSTONE SIMON N. 32,058 38.2900 32,058 38.2900 1,227,501
2022-08-16 XENE PIMSTONE SIMON N. 20,000 38.8700 20,000 38.8700 777,400
2022-08-15 XENE PIMSTONE SIMON N. 33,942 37.7600 33,942 37.7600 1,281,650
2022-08-12 XENE PIMSTONE SIMON N. 43,135 37.9100 43,135 37.9100 1,635,248
2022-08-12 XENE PIMSTONE SIMON N. 47,000 38.6000 47,000 38.6000 1,814,200
2022-08-12 XENE PIMSTONE SIMON N. 1,000 39.1500 1,000 39.1500 39,150
2022-03-08 XENE PIMSTONE SIMON N. 2,051 30.6000 2,051 30.6000 62,761
2022-03-08 XENE PIMSTONE SIMON N. 2,500 3.8000 2,500 3.8000 9,500
2022-03-08 XENE PIMSTONE SIMON N. 2,500 30.1000 2,500 30.1000 75,250
2022-03-08 XENE PIMSTONE SIMON N. 2,500 30.2000 2,500 30.2000 75,500
2022-03-08 XENE PIMSTONE SIMON N. 2,500 30.5500 2,500 30.5500 76,375
2022-03-08 XENE PIMSTONE SIMON N. 2,500 30.5000 2,500 30.5000 76,250
2022-03-08 XENE PIMSTONE SIMON N. 2,500 30.8000 2,500 30.8000 77,000
2022-03-07 XENE PIMSTONE SIMON N. 5,037 30.6000 5,037 30.6000 154,132
2022-03-07 XENE PIMSTONE SIMON N. 4,517 30.4900 4,517 30.4900 137,723
2022-03-07 XENE PIMSTONE SIMON N. 4,516 30.4500 4,516 30.4500 137,512
2022-03-07 XENE PIMSTONE SIMON N. 4,516 30.4400 4,516 30.4400 137,467
2022-03-07 XENE PIMSTONE SIMON N. 2,500 30.5200 2,500 30.5200 76,300
2022-03-07 XENE PIMSTONE SIMON N. 7,500 30.5000 7,500 30.5000 228,750
2022-03-07 XENE PIMSTONE SIMON N. 2,500 30.5500 2,500 30.5500 76,375
2022-03-04 XENE PIMSTONE SIMON N. 4,532 30.6600 4,532 30.6600 138,951
2022-03-04 XENE PIMSTONE SIMON N. 4,793 30.5600 4,793 30.5600 146,474
2021-11-15 XENE PIMSTONE SIMON N. 17,557 31.3300 17,557 31.3300 550,061
2020-06-01 XENE PIMSTONE SIMON N. 3,000 14.4300 3,000 14.4300 43,290
2020-05-29 XENE PIMSTONE SIMON N. 5,000 13.9900 5,000 13.9900 69,950
2019-09-20 XENE PIMSTONE SIMON N. 10,395 9.5100 10,395 9.5100 98,856

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

XENE / Xenon Pharmaceuticals Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Pimstone Simon N. as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2023-06-01 2023-06-01 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -24,255 6,000 -80.17 38.78 -940,609 232,680
2023-06-01 2023-06-01 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
F - Taxes -20,745 30,255 -40.68 38.53 -799,305 1,165,725
2023-06-01 2023-06-01 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
M - Exercise 45,000 51,000 750.00 17.76 799,200 905,760
2023-06-01 2023-06-01 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -7,458 6,000 -55.42 38.97 -290,638 233,820
2023-06-01 2023-06-01 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
F - Taxes -1,860 13,458 -12.14 38.53 -71,666 518,537
2023-06-01 2023-06-01 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
M - Exercise 9,318 15,318 155.30 7.69 71,655 117,795
2023-06-01 2023-05-31 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -26,856 6,000 -81.74 38.69 -1,039,059 232,140
2023-06-01 2023-05-31 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
F - Taxes -23,144 32,856 -41.33 38.37 -888,035 1,260,685
2023-06-01 2023-05-31 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
M - Exercise 50,000 56,000 833.33 17.76 888,000 994,560
2023-06-01 2023-05-31 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -23,670 6,000 -79.78 38.81 -918,633 232,860
2023-06-01 2023-05-31 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
F - Taxes -6,165 29,670 -17.20 38.37 -236,551 1,138,438
2023-06-01 2023-05-31 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
M - Exercise 29,835 35,835 497.25 9.85 293,875 352,975
2023-06-01 2023-05-31 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -12,000 6,000 -66.67 38.53 -462,360 231,180
2023-06-01 2023-05-30 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -19,000 18,000 -51.35 39.90 -758,100 718,200
2023-06-01 2023-05-30 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -18,006 37,000 -32.73 38.63 -695,572 1,429,310
2023-03-09 2023-03-07 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -8,242 55,006 -13.03 36.94 -304,459 2,031,922
2023-03-09 2023-03-07 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
F - Taxes -1,618 63,248 -2.49 37.13 -60,076 2,348,398
2023-03-09 2023-03-07 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
M - Exercise 30,864 64,866 90.77 2.59 79,938 168,003
2023-03-09 2023-03-07 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -10,990 34,002 -24.43 37.01 -406,740 1,258,414
2023-03-09 2023-03-07 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
F - Taxes -2,160 44,992 -4.58 37.13 -80,201 1,670,553
2023-03-09 2023-03-07 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
M - Exercise 41,152 47,152 685.87 2.68 110,287 126,367
2022-08-16 2022-08-16 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -20,000 6,000 -76.92 38.87 -777,400 233,220
2022-08-16 2022-08-16 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -32,058 26,000 -55.22 38.29 -1,227,501 995,540
2022-08-16 2022-08-15 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -33,942 58,058 -36.89 37.76 -1,281,650 2,192,270
2022-08-16 2022-08-12 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -1,000 92,000 -1.08 39.15 -39,150 3,601,800
2022-08-16 2022-08-12 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -47,000 93,000 -33.57 38.60 -1,814,200 3,589,800
2022-08-16 2022-08-12 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -43,135 140,000 -23.55 37.91 -1,635,248 5,307,400
2022-03-14 2022-03-10 4 XENE Xenon Pharmaceuticals Inc.
Stock Option (Right to Buy)
A - Award 25,000 25,000
2022-03-08 2022-03-08 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -2,500 183,135 -1.35 30.50 -76,250 5,585,618
2022-03-08 2022-03-08 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -2,500 185,635 -1.33 30.55 -76,375 5,671,149
2022-03-08 2022-03-08 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -2,500 188,135 -1.31 30.20 -75,500 5,681,677
2022-03-08 2022-03-08 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -2,500 190,635 -1.29 30.10 -75,250 5,738,114
2022-03-08 2022-03-08 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -2,500 193,135 -1.28 3.80 -9,500 733,913
2022-03-08 2022-03-08 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -2,051 195,635 -1.04 30.60 -62,761 5,986,431
2022-03-08 2022-03-07 4 XENE Xenon Pharmaceuticals Inc.
Stock Option (Right to Buy)
M - Exercise -20,576 0 -100.00
2022-03-08 2022-03-07 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -2,500 197,686 -1.25 30.55 -76,375 6,039,307
2022-03-08 2022-03-07 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -7,500 200,186 -3.61 30.50 -228,750 6,105,673
2022-03-08 2022-03-07 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -2,500 207,686 -1.19 30.52 -76,300 6,338,577
2022-03-08 2022-03-07 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -4,516 210,186 -2.10 30.44 -137,467 6,398,062
2022-03-08 2022-03-07 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -4,516 214,702 -2.06 30.45 -137,512 6,537,676
2022-03-08 2022-03-07 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -4,517 219,218 -2.02 30.49 -137,723 6,683,957
2022-03-08 2022-03-07 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -5,037 223,735 -2.20 30.60 -154,132 6,846,291
2022-03-08 2022-03-07 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
F - Taxes -1,990 228,772 -0.86 30.23 -60,158 6,915,778
2022-03-08 2022-03-07 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
M - Exercise 20,576 230,762 9.79 3.67 75,514 846,897
2022-03-08 2022-03-04 4 XENE Xenon Pharmaceuticals Inc.
Stock Option (Right to Buy)
M - Exercise -10,288 0 -100.00
2022-03-08 2022-03-04 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -4,793 210,186 -2.23 30.56 -146,474 6,423,284
2022-03-08 2022-03-04 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -4,532 214,979 -2.06 30.66 -138,951 6,591,256
2022-03-08 2022-03-04 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
F - Taxes -963 219,511 -0.44 31.42 -30,257 6,897,036
2022-03-08 2022-03-04 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
M - Exercise 10,288 220,474 4.89 3.67 37,757 809,140
2022-03-08 2022-03-08 4/A XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -2,500 193,135 -1.28 30.80 -77,000 5,948,558
2021-11-16 2021-11-15 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -17,557 210,186 -7.71 31.33 -550,061 6,585,127
2021-05-26 2021-05-24 4 XENE Xenon Pharmaceuticals Inc.
Stock Option (Right to Buy)
M - Exercise -22,633 0 -100.00
2021-05-26 2021-05-24 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
F - Taxes -5,076 227,743 -2.18 19.17 -97,307 4,365,833
2021-05-26 2021-05-24 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
M - Exercise 22,633 232,819 10.77 3.76 85,100 875,399
2021-03-15 2021-03-12 4 XENE Xenon Pharmaceuticals Inc.
Stock Option (Right to Buy)
A - Award 225,000 225,000
2020-08-24 2020-08-20 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
J - Other -45,000 210,186 -17.63
2020-06-02 2020-06-01 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -3,000 255,186 -1.16 14.43 -43,290 3,682,334
2020-06-02 2020-05-29 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -5,000 258,186 -1.90 13.99 -69,950 3,612,022
2020-05-28 2020-05-26 4 XENE Xenon Pharmaceuticals Inc.
Stock Option (Right to Buy)
M - Exercise -6,172 0 -100.00
2020-05-28 2020-05-26 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
F - Taxes -1,108 263,186 -0.42 14.90 -16,509 3,921,471
2020-05-28 2020-05-26 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
M - Exercise 6,172 264,294 2.39 3.56 21,972 940,887
2020-03-13 2020-03-12 4 XENE Xenon Pharmaceuticals Inc.
Stock Option (Right to Buy)
A - Award 280,000 280,000
2019-09-24 2019-09-20 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
S - Sale -10,395 258,122 -3.87 9.51 -98,856 2,454,740
2019-09-18 2019-09-17 4 XENE Xenon Pharmaceuticals Inc.
Stock Option (Right to Buy)
M - Exercise -12,345 0 -100.00
2019-09-18 2019-09-17 4 XENE Xenon Pharmaceuticals Inc.
Stock Option (Right to Buy)
M - Exercise -9,259 0 -100.00
2019-09-18 2019-09-17 4 XENE Xenon Pharmaceuticals Inc.
Stock Option (Right to Buy)
M - Exercise -36,008 0 -100.00
2019-09-18 2019-09-17 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
F - Taxes -3,692 268,517 -1.36 9.44 -34,852 2,534,800
2019-09-18 2019-09-17 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
M - Exercise 12,345 272,209 4.75 3.38 41,726 920,066
2019-09-18 2019-09-17 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
F - Taxes -2,769 259,864 -1.05 9.44 -26,139 2,453,116
2019-09-18 2019-09-17 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
M - Exercise 9,259 262,633 3.65 3.07 28,425 806,283
2019-09-18 2019-09-17 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
F - Taxes -10,769 253,374 -4.08 9.44 -101,659 2,391,851
2019-09-18 2019-09-17 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
M - Exercise 36,008 264,143 15.78 3.70 133,230 977,329
2019-09-18 2019-09-16 4 XENE Xenon Pharmaceuticals Inc.
Stock Option (Right to Buy)
A - Award 280,000 280,000
2018-03-14 2018-03-12 4 XENE Xenon Pharmaceuticals Inc.
Stock Option (Right to Buy)
M - Exercise -10,288 0 -100.00
2018-03-14 2018-03-12 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
M - Exercise 10,288 228,135 4.72 3.77 38,786 860,069
2018-03-13 2018-03-12 4 XENE Xenon Pharmaceuticals Inc.
Stock Option (Right to Buy)
A - Award 140,000 140,000
2017-10-24 2017-10-23 4 XENE Xenon Pharmaceuticals Inc.
Stock Option (Right to Buy)
A - Award 11,000 11,000
2017-08-14 2017-08-10 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
P - Purchase 6,000 217,847 2.83 2.90 17,400 631,756
2017-03-14 2017-03-13 4 XENE Xenon Pharmaceuticals Inc.
Stock Option (Right to Buy)
A - Award 140,000 140,000
2016-08-02 2016-07-29 4 XENE Xenon Pharmaceuticals Inc.
Stock Option (Right to Buy)
M - Exercise -12,345 0 -100.00
2016-08-02 2016-07-29 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
F - Taxes -4,703 211,847 -2.17 7.46 -35,084 1,580,379
2016-08-02 2016-07-29 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
M - Exercise 12,345 216,550 6.05 3.30 40,738 714,615
2016-03-11 2016-03-11 4 XENE Xenon Pharmaceuticals Inc.
Stock Option (Right to Buy)
A - Award 50,000 50,000
2015-12-21 2015-12-18 4 XENE Xenon Pharmaceuticals Inc.
Stock Option (Right to Buy)
A - Award 40,000 40,000
2015-08-20 2015-08-18 4 XENE Xenon Pharmaceuticals Inc.
Stock Option (Right to Buy)
M - Exercise -15,432 0 -100.00
2015-08-20 2015-08-18 4 XENE Xenon Pharmaceuticals Inc.
Stock Option (Right to Buy)
M - Exercise -5,144 0 -100.00
2015-08-20 2015-08-18 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
F - Taxes -6,508 204,205 -3.09 11.00 -71,588 2,246,255
2015-08-20 2015-08-18 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
M - Exercise 15,432 210,713 7.90 4.98 76,851 1,049,351
2015-08-20 2015-08-18 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
F - Taxes -2,170 195,281 -1.10 11.00 -23,870 2,148,091
2015-08-20 2015-08-18 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
M - Exercise 5,144 197,451 2.67 4.81 24,743 949,739
2015-03-19 2015-03-17 4 XENE Xenon Pharmaceuticals Inc.
Stock Option (Right to Buy)
A - Award 95,000 95,000
2014-11-12 2014-11-09 4 XENE Xenon Pharmaceuticals Inc.
Series B Preferred Shares
C - Conversion -1,914 0 -100.00
2014-11-12 2014-11-09 4 XENE Xenon Pharmaceuticals Inc.
Series A Preferred Shares
C - Conversion -964 0 -100.00
2014-11-12 2014-11-09 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
C - Conversion 1,914 192,307 1.01
2014-11-12 2014-11-09 4 XENE Xenon Pharmaceuticals Inc.
Common Shares
C - Conversion 964 190,393 0.51
2014-11-04 3 XENE Xenon Pharmaceuticals Inc.
Common Shares
395,318
2014-11-04 3 XENE Xenon Pharmaceuticals Inc.
Common Shares
222,349
2014-11-04 3 XENE Xenon Pharmaceuticals Inc.
Common Shares
395,318
2014-11-04 3 XENE Xenon Pharmaceuticals Inc.
Common Shares
222,349
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)